Click Here to Read: A Drug Trial’s Frayed Promise By Katie Thomas in The New York Times on April 17, 2015.
Carl Elliott, a bioethicist at the University of Minnesota, filed a complaint with the Food and Drug Administration about the university’s research practices in the Seroquel XR study. CreditJenn Ackerman for The New York Times